Protein kinase Cδ and caspase-3 modulate TRAIL-induced apoptosis in breast tumor cells

Journal of Cellular Biochemistry

Volumn 111, Issue 4, 2010, Pages 979-987

  Yin, Shuping ^a   Sethi, Seema ^a   Reddy, Kaladhar B ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; Caspase 3; PKC ; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; PROTEIN KINASE C DELTA; ROTTLERIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL DIVISION; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; WILD TYPE;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CYTOPROTECTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN KINASE C-DELTA; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78049261002     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22786     Document Type: Article

References (42)

1. Ashkenazi A, Dixit VM. 1998. Death receptors: Signaling and modulation. Science 281: 1305-1308.
2. Basu A, Woolard MD, Johnson CL. 2001. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. Cell Death Differ 8: 899-908.
3. Blass M, Kronfeld I, Kazimirsky G, Blumberg PM, Brodie C. 2002. Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 22: 182-195.
4. Brodie C, Blumberg PM. 2003. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8: 19-27.
5. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7: 821-830.
6. Chen N, Ma W, Huang C, Dong Z. 1999. Translocation of protein kinase Cepsilon and protein kinase Cdelta to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. J Biol Chem 274: 15389-15394.
7. Clark AS, West KA, Blumberg PM, Dennis PA. 2003. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res 63: 780-786.
8. D'Costa AM, Denning MF. 2005. A caspase-resistant mutant of PKC-delta protects keratinocytes from UV-induced apoptosis. Cell Death Differ 12: 224-232.
9. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH, Tora AD, Mehta K. 2002. Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21: 8843-8851.
10. DeVries TA, Neville MC, Reyland ME. 2002. Nuclear import of PKCdelta is required for apoptosis: Identification of a novel nuclear import sequence. EMBO J 21: 6050-6060.
11. DeVries-Seimon TA, Ohm AM, Humphries MJ, Reyland ME. 2007. Induction of apoptosis is driven by nuclear retention of protein kinase C delta. J Biol Chem 282: 22307-22314.
12. Earnshaw WC, Martins LM, Kaufmann SH. 1999. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424.
13. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R, Kufe D. 1995. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 14: 6148-6156.
14. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jaattela M. 2001. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153: 999-1010.
15. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, Pandey P, Datta R, Huang Y, Kharbanda S, Allen H, Kamen R, Wong W, Kufe D. 1996. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184: 2399-2404.
16. Griffith TS, Lynch DH. 1998. TRAIL: A molecule with multiple receptors and control mechanisms. Curr Opin Immunol 10: 559-563.
17. Herr I, Debatin KM. 2001. Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614.
18. Humphries MJ, Limesand KH, Schneider JC, Nakayama KI, Anderson SM, Reyland ME. 2006. Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo. J Biol Chem 281: 9728-9737.
19. Jackson DN, Foster DA. 2004. The enigmatic protein kinase Cdelta: Complex roles in cell proliferation and survival. FASEB J 18: 627-636.
20. Janicke RU, Sprengart ML, Wati MR, Porter AG. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360.
21. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG. 2005. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem 280: 28721-28730.
22. Kerfoot C, Huang W, Rotenberg SA. 2004. Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C alpha. J Histochem Cytochem 52: 419-422.
23. Lin J, Zhang Z, Zeng S, Zhou S, Liu BF, Liu Q, Yang J, Luo Q. 2006. TRAIL-induced apoptosis proceeding from caspase-3-dependent and -independent pathways in distinct HeLa cells. Biochem Biophys Res Commun 346: 1136-1141.
24. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272: 25417-25420.
25. Mackay HJ, Twelves CJ. 2007. Targeting the protein kinase C family: Are we there yet? Nat Rev Cancer 7: 554-562.
26. McCracken MA, Miraglia LJ, McKay RA, Strobl JS. 2003. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol Cancer Ther 2: 273-281.
27. Nabha SM, Glaros S, Hong M, Lykkesfeldt AE, Schiff R, Osborne K, Reddy KB. 2005. Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells. Oncogene 24: 3166-3176.
28. Newton AC. 1995. Protein kinase C: Structure, function, and regulation. J Biol Chem 270: 28495-28498.
29. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. 2000. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 97: 7871-7876.
30. Okhrimenko H, Lu W, Xiang C, Ju D, Blumberg PM, Gomel R, Kazimirsky G, Brodie C. 2005. Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. J Biol Chem 280: 23643-23652.
31. Otieno MA, Kensler TW. 2000. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress. Cancer Res 60: 4391-4396.
32. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. 1997a. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818.
33. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. 1997b. The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
34. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7: 831-836.
35. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821.
36. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H. 2000. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12: 599-609.
37. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6: 529-535.
38. Tillman DM, Izeradjene K, Szucs KS, Douglas L, Houghton JA. 2003. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res 63: 5118-5125.
39. Visscher DW, Sarkar FH, Kasunic TC, Reddy KB. 1997. Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia. Breast Cancer Res Treat 45: 75-80.
40. Winter RN, Kramer A, Borkowski A, Kyprianou N. 2001. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 61: 1227-1232.
41. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW. 1998. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954-1958.
42. Zhang J, Liu N, Zhang J, Liu S, Liu Y, Zheng D. 2005. PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis. J Cell Biochem 96: 522-532.